EMEA-001554-PIP01-13-M02

Key facts

Invented name
Parsabiv
Active substance
Etelcalcetide
Therapeutic area
Uro-nephrology
Decision number
P/0173/2018
PIP number
EMEA-001554-PIP01-13-M02
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of hyperparathyroidism
Route(s) of administration
Intravenous use
Contact for public enquiries
Amgen Europe B.V. 

E-mail: medinfointernational@amgen.com
Tel. +44 (0)1223 420305

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating